Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GSK plc (GSK) vs Progressive Corp (PGR) Price & Performance

Progressive CorpTrade

Price performance (Past 24H)

Key statistics

GSK plc vs Progressive Corp — how do they compare? GSK plc trades at $50.33 (market cap $102.60B), while Progressive Corp trades at $207.48 (market cap $123.45B). The key difference: Progressive Corp is the larger of the two by market cap, and Progressive Corp pays the higher dividend (6.55%). Which is the better fit depends on your goals.

GSKPGR
Market Cap
$102.60B$123.45B
Sector
HealthFinancials
52-Week High
$61.18$252.68
52-Week Low
$38.22$190.40
Enterprise Value
$123.04B$131.66B
Dividend Yield
3.57%6.55%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GSK plc

GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.

The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.

Progressive Corp

PGR trades at $208.28, down 2.65% on the day, with a bearish technical signal. The stock shows strong fundamentals with a P/E of 10.65, net income margin of 12.85%, and robust revenue growth from $49.6B in 2022 to $87.6B in 2025. Recent Q2 2026 earnings beat expectations at $4.85 EPS, though Q1 2026 missed. Analyst consensus is a buy with a $231.20 price target, but technical indicators suggest near-term caution.

Outlook remains positive due to solid profitability and growth, but risks include competitive pressures and potential margin compression. The stock offers value at current levels with upside to analyst targets, though investors should monitor execution on growth initiatives and industry dynamics.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About GSK plc

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

Read more on GSK

About Progressive Corp

Progressive underwrites private and commercial auto insurance and specialty lines

Read more on PGR